Immunoglobulin Infusion as Therapy Against Influenza?

Por Huckriede, Anke
Publicado no EBioMedicine (2017)

Safety and tolerability evaluation of the use of Montanide ISA™51 as vaccine adjuvant: A systematic review

Por van Doorn, Eva, Liu, Heng, Huckriede, Anke, Hak, Eelko
Publicado no Hum Vaccin Immunother (2015)

Distinctive Responses in an In Vitro Human Dendritic Cell-Based System upon Stimulation with Different Influenza Vaccine Formulations

Por Tapia-Calle, Gabriela, Stoel, Maaike, de Vries-Idema, Jacqueline, Huckriede, Anke
Publicado no Vaccines (Basel) (2017)

Enhancement of the Immunogenicity and Protective Efficacy of a Mucosal Influenza Subunit Vaccine by the Saponin Adjuvant GPI-0100

Por Liu, Heng, Patil, Harshad P., de Vries-Idema, Jacqueline, Wilschut, Jan, Huckriede, Anke
Publicado em 2012

Evaluation of Mucosal and Systemic Immune Responses Elicited by GPI-0100- Adjuvanted Influenza Vaccine Delivered by Different Immunization Strategies

Por Liu, Heng, Patil, Harshad P., de Vries-Idema, Jacqueline, Wilschut, Jan, Huckriede, Anke
Publicado em 2013

Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs

Por Geeraedts, Felix, Bungener, Laura, Pool, Judith, Ter Veer, Wouter, Wilschut, Jan, Huckriede, Anke
Publicado no Influenza Other Respir Viruses (2008)

Simplifying Influenza Vaccination During Pandemics: Sublingual Priming and Intramuscular Boosting of Immune Responses with Heterologous Whole Inactivated Influenza Vaccine

Por Murugappan, Senthil, Patil, Harshad P., Frijlink, Henderik W., Huckriede, Anke, Hinrichs, Wouter L. J.
Publicado em 2014

Heterosubtypic cross‐protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration

Por Budimir, Natalija, de Haan, Aalzen, Meijerhof, Tjarko, Gostick, Emma, Price, David A., Huckriede, Anke, Wilschut, Jan
Publicado em 2013

Induction of Heterosubtypic Cross-Protection against Influenza by a Whole Inactivated Virus Vaccine: The Role of Viral Membrane Fusion Activity

Por Budimir, Natalija, Huckriede, Anke, Meijerhof, Tjarko, Boon, Louis, Gostick, Emma, Price, David A., Wilschut, Jan, de Haan, Aalzen
Publicado em 2012

Cellular gene transfer mediated by influenza virosomes with encapsulated plasmid DNA

Por de Jonge, Jørgen, Leenhouts, Johanna M., Holtrop, Marijke, Schoen, Pieter, Scherrer, Peter, Cullis, Pieter R., Wilschut, Jan, Huckriede, Anke
Publicado em 2007

Superior Immunogenicity of Inactivated Whole Virus H5N1 Influenza Vaccine is Primarily Controlled by Toll-like Receptor Signalling

Por Geeraedts, Felix, Goutagny, Nadege, Hornung, Veit, Severa, Martina, de Haan, Aalzen, Pool, Judith, Wilschut, Jan, Fitzgerald, Katherine A., Huckriede, Anke
Publicado em 2008

Intranasal Delivery of Influenza Subunit Vaccine Formulated with GEM Particles as an Adjuvant

Por Saluja, Vinay, Amorij, Jean P., van Roosmalen, Maarten L., Leenhouts, Kees, Huckriede, Anke, Hinrichs, Wouter L. J., Frijlink, Henderik W.
Publicado em 2010

Critical Role of TLR7 Signaling in the Priming of Cross-Protective Cytotoxic T Lymphocyte Responses by a Whole Inactivated Influenza Virus Vaccine

Por Budimir, Natalija, de Haan, Aalzen, Meijerhof, Tjarko, Waijer, Simke, Boon, Louis, Gostick, Emma, Price, David A., Wilschut, Jan, Huckriede, Anke
Publicado em 2013

Innate Responses Induced by Whole Inactivated Virus or Subunit Influenza Vaccines in Cultured Dendritic Cells Correlate with Immune Responses In Vivo

Por Stoel, Maaike, Pool, Judith, de Vries-Idema, Jacqueline, Zaaraoui-Boutahar, Fatiha, Bijl, Maarten, Andeweg, Arno C., Wilschut, Jan, Huckriede, Anke
Publicado no PLoS One (2015)

Preservation of the Immunogenicity of Dry-powder Influenza H5N1 Whole Inactivated Virus Vaccine at Elevated Storage Temperatures

Por Geeraedts, Felix, Saluja, Vinay, ter Veer, Wouter, Amorij, Jean-Pierre, Frijlink, Henderik W., Wilschut, Jan, Hinrichs, Wouter L. J., Huckriede, Anke
Publicado em 2010

Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation

Por Patil, Harshad P., Herrera Rodriguez, José, de Vries-Idema, Jacqueline, Meijerhof, Tjarko, Frijlink, Henderik W., Hinrichs, Wouter L. J., Huckriede, Anke
Publicado no Vaccines (Basel) (2017)

Intracytoplasmic Trapping of Influenza Virus by a Lipophilic Derivative of Aglycoristocetin

Por Vanderlinden, Evelien, Vanstreels, Els, Boons, Eline, ter Veer, Wouter, Huckriede, Anke, Daelemans, Dirk, Van Lommel, Alfons, Rőth, Erzsébet, Sztaricskai, Ferenc, Herczegh, Pàl, Naesens, Lieve
Publicado em 2012

Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center,...

Por van Doorn, Eva, Pleguezuelos, Olga, Liu, Heng, Fernandez, Ana, Bannister, Robin, Stoloff, Gregory, Oftung, Fredrik, Norley, Stephen, Huckriede, Anke, Frijlink, Henderik W., Hak, Eelko
Publicado no BMC Infect Dis (2017)

GLA-SE, a Synthetic Toll-like Receptor 4 Agonist, Enhances T-Cell Responses to Influenza Vaccine in Older Adults

Por Behzad, Hayedeh, Huckriede, Anke L. W., Haynes, Laura, Gentleman, Beth, Coyle, Krysta, Wilschut, Jan C., Kollmann, Tobias R., Reed, Steven G., McElhaney, Janet E.
Publicado em 2012